Production cell line enhancers
    2.
    发明授权

    公开(公告)号:US10351622B2

    公开(公告)日:2019-07-16

    申请号:US15624982

    申请日:2017-06-16

    摘要: The present invention relates to discovery of the ectopic expression of EDEM2 in a production cell to improve the yield of a useful multi-subunit protein. Thus, the present invention provides for production cell lines, such as the canonical mammalian biopharmaceutical production cell, the CHO cell, containing recombinant polynucleotides encoding EDEM2. Also disclosed is a production cell containing both an EDEM2-encoding polynucleotide as well an XBP1-encoding polynucleotide. Improved titers of antibodies produced by these cell lines are disclosed, as well as the improved cell densities attained by these cells in culture.

    Fucosylation-deficient cells
    3.
    发明授权
    Fucosylation-deficient cells 有权
    岩藻糖基化缺陷型细胞

    公开(公告)号:US09206455B2

    公开(公告)日:2015-12-08

    申请号:US13779952

    申请日:2013-02-28

    摘要: An isolated nucleic acid encoding an FX protein having a serine at position 79, a lysine at position 90, a leucine at position 136, an arginine at position 211, a serine at position 289, and a combination thereof is provided. Cells having a gene encoding a modified FX protein are provided, wherein the cells exhibit a reduced ability to fucosylate a glycoprotein at a first temperature, but exhibit the ability to fucosylate the glycoprotein at a second temperature. Methods and compositions for making glycoproteins with reduced fucosylation are provided.

    摘要翻译: 提供了编码FX蛋白的分离核酸,其在79位具有丝氨酸,在90位具有赖氨酸,136位的亮氨酸,211位的精氨酸,289位的丝氨酸及其组合。 提供具有编码经修饰的FX蛋白的基因的细胞,其中细胞在第一温度下表现出降低糖蛋白岩藻糖化能力,但在第二温度下表现出对糖蛋白的岩藻糖化能力。 提供了用于制备具有降低的岩藻糖基化的糖蛋白的方法和组合物。

    EFFICIENT SELECTIVITY OF RECOMBINANT PROTEINS

    公开(公告)号:US20210340564A1

    公开(公告)日:2021-11-04

    申请号:US17366239

    申请日:2021-07-02

    IPC分类号: C12N15/85 C12P21/00

    摘要: The invention provides a new expression system comprising a mammalian selectable marker that promotes desirable post-translational modifications of glycoproteins. In particular, the invention includes methods and compositions for optimal recombinant protein expression in mammalian cells by employing a selection marker system based on GPT genes of mammalian origin. The invention includes methods that facilitate selectivity and enhanced expression copies as well as protein yield of recombinant proteins in mammalian cells, and methods of using GPT expression systems.

    PRODUCTION CELL LINE ENHANCERS
    7.
    发明申请

    公开(公告)号:US20190270800A1

    公开(公告)日:2019-09-05

    申请号:US16417792

    申请日:2019-05-21

    摘要: The present invention relates to discovery of the ectopic expression of EDEM2 in a production cell to improve the yield of a useful multi-subunit protein. Thus, the present invention provides for production cell lines, such as the canonical mammalian biopharmaceutical production cell, the CHO cell, containing recombinant polynucleotides encoding EDEM2. Also disclosed is a production cell containing both an EDEM2-encoding polynucleotide as well an XBP1-encoding polynucleotide. Improved titers of antibodies produced by these cell lines are disclosed, as well as the improved cell densities attained by these cells in culture.

    Production cell line enhancers
    9.
    发明授权
    Production cell line enhancers 有权
    生产细胞系增强剂

    公开(公告)号:US09193786B2

    公开(公告)日:2015-11-24

    申请号:US14754112

    申请日:2015-06-29

    摘要: The present invention relates to discovery of the ectopic expression of EDEM2 in a production cell to improve the yield of a useful multi-subunit protein. Thus, the present invention provides for production cell lines, such as the canonical mammalian biopharmaceutical production cell—the CHO cell, containing recombinant polynucleotides encoding EDEM2. Also disclosed is a production cell containing both an EDEM2-encoding polynucleotide as well an XBP1-encoding polynucleotide. Improved titers of antibodies produced by these cell lines are disclosed, as well as the improved cell densities attained by these cells in culture.

    摘要翻译: 本发明涉及在生产细胞中发现EDEM2的异位表达以改善有用的多亚单位蛋白的产量。 因此,本发明提供了生产细胞系,例如含有编码EDEM2的重组多核苷酸的规范哺乳动物生物制药生产细胞 - CHO细胞。 还公开了含有EDEM2编码多核苷酸以及编码XBP1的多核苷酸两者的生产细胞。 公开了由这些细胞系产生的抗体的改善的滴度,以及培养中由这些细胞获得的改善的细胞密度。